203 related articles for article (PubMed ID: 11120572)
1. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.
Kowluru RA; Engerman RL; Kern TS
Curr Eye Res; 2000 Oct; 21(4):814-9. PubMed ID: 11120572
[TBL] [Abstract][Full Text] [Related]
2. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy.
Kowluru RA; Engerman RL; Kern TS
Free Radic Biol Med; 1999 Feb; 26(3-4):371-8. PubMed ID: 9895229
[TBL] [Abstract][Full Text] [Related]
4. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat.
Kowluru RA
Curr Eye Res; 2002 Feb; 24(2):123-8. PubMed ID: 12187484
[TBL] [Abstract][Full Text] [Related]
5. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated.
Kowluru RA
Acta Diabetol; 2001 Dec; 38(4):179-85. PubMed ID: 11855796
[TBL] [Abstract][Full Text] [Related]
6. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
Kowluru RA; Koppolu P
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3287-91. PubMed ID: 12356836
[TBL] [Abstract][Full Text] [Related]
7. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.
Du Y; Smith MA; Miller CM; Kern TS
J Neurochem; 2002 Mar; 80(5):771-9. PubMed ID: 11948240
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
Kowluru RA; Tang J; Kern TS
Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.
Kowluru RA; Kern TS; Engerman RL; Armstrong D
Diabetes; 1996 Sep; 45(9):1233-7. PubMed ID: 8772728
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione.
Kern TS; Kowluru RA; Engerman RL
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2962-7. PubMed ID: 8206713
[TBL] [Abstract][Full Text] [Related]
11. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
Agardh E; Hultberg B; Agardh C
Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
[TBL] [Abstract][Full Text] [Related]
13. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.
Kowluru RA; Kern TS; Engerman RL
Free Radic Biol Med; 1997; 22(4):587-92. PubMed ID: 9013121
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.
Kowluru RA; Jirousek MR; Stramm L; Farid N; Engerman RL; Kern TS
Diabetes; 1998 Mar; 47(3):464-9. PubMed ID: 9519755
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA; Menon B; Gierhart DL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[TBL] [Abstract][Full Text] [Related]
17. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.
Du Y; Sarthy VP; Kern TS
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R735-41. PubMed ID: 15371279
[TBL] [Abstract][Full Text] [Related]
18. Retinal glutamate in diabetes and effect of antioxidants.
Kowluru RA; Engerman RL; Case GL; Kern TS
Neurochem Int; 2001 Apr; 38(5):385-90. PubMed ID: 11222918
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy.
Kowluru RA; Engerman RL; Kern TS
Free Radic Res; 2000 Jan; 32(1):67-74. PubMed ID: 10625218
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy.
Kowluru R; Kern TS; Engerman RL
Curr Eye Res; 1994 Dec; 13(12):891-6. PubMed ID: 7720397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
